Your browser doesn't support javascript.
loading
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
Kwong, Y L; Kim, S J; Tse, E; Oh, S Y; Kwak, J Y; Eom, H S; Do, Y R; Mun, Y C; Lee, S R; Shin, H J; Suh, C; Chuang, S S; Lee, Y S; Lim, S T; Izutsu, K; Suzuki, R; Relander, T; d'Amore, F; Schmitz, N; Jaccard, A; Kim, W S.
Afiliación
  • Kwong YL; Department of Medicine, Queen Mary Hospital, Hong Kong, China.
  • Kim SJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Tse E; Department of Medicine, Queen Mary Hospital, Hong Kong, China.
  • Oh SY; Department of Medicine, Dong-A University Medical Center, Busan, Korea.
  • Kwak JY; Chonbuk National University Medical School, Jeonju, Korea.
  • Eom HS; National Cancer Center, Seoul, Korea.
  • Do YR; Department of Medicine, Keimyung University Dongsan Medical Center, Deagu, Korea.
  • Mun YC; Ewha Womans University Mokdong Hospital, Seoul, Korea.
  • Lee SR; Department of Medicine, Korea University Ansan Hospital, Ansan, Korea.
  • Shin HJ; Pusan National University Hospital, Pusan, Korea.
  • Suh C; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Chuang SS; Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.
  • Lee YS; Department of Haematology, Singapore General Hospital, Singapore.
  • Lim ST; National Cancer Centre, Singapore.
  • Izutsu K; Toranomon Hospital, Tokyo, Japan.
  • Suzuki R; Department of Hematology and Oncology, Shimane University Cancer Center, Izumo, Japan.
  • Relander T; Department of Oncology, Skane University Hospital, Lund, Sweden.
  • d'Amore F; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Schmitz N; Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Hospital St. Georg, Hamburg, Germany.
  • Jaccard A; Department of Hematology, Centre Hospitalier Universitaire (CHU) Limoges, Limoges, France.
  • Kim WS; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Oncol ; 29(1): 256-263, 2018 01 01.
Article en En | MEDLINE | ID: mdl-29077846

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Extranodal de Células NK-T Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Extranodal de Células NK-T Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido